Aguilar, Daniel
Lemonnier, Nathanaël
Melén, Erik
Bustamante, Mariona
Gruzieva, Olena
Guerra, Stefano
Keil, Thomas
Koppelman, Gerard H.
Celedón, Juan C.
Antó, Josep M.
Bousquet, Jean
Article History
Received: 16 April 2023
Accepted: 3 August 2023
First Online: 12 August 2023
Competing interests
: DA reports personal fees from MASK-AIR SAS, outside the submitted work. JB reports personal fees from Cipla, Menarini, Mylan, Novartis, Purina, Sanofi-Aventis, Teva, Uriach, other from KYomed-Innov, other from Mask-air-SAS, outside the submitted work. JCC reports other from GSK, other from Merck, other from Pharmavite, outside the submitted work. GHK reports grants from Netherlands Lung Foundation, TEVA, VERTEX, GSK, Ubbo Emmius Foundation, European Union, Zon MW (Vici Grant), outside the submitted work; and GHK participated in advisory boards to GSK, AZ and Pure-IMS (Money to institution). The other authors have no COIs to disclose, outside the submitted work.